Corbus Pharmaceuticals Holdings Inc. conducted its annual meeting of stockholders on May 15, 2025. During the meeting, stockholders voted on the election of directors, the ratification of EisnerAmper LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, and all proposals were approved. Additionally, Rachelle Jacques was appointed as Chair of the Board, succeeding Alan Holmer, who will remain on the Board.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.